Search | IOVS | ARVO Journals

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Effects of melatonin on human Retinal Pigment Epithelial cells (ARPE-19) and Müller cells (MIO-M1) exposed to cobalt chloride (CoCl2) in vitro

Paula Sakemi Fukuhara; Daniel Hyunjae Lee; Noor-Ul-Ain Shekoh; Marilyn Chwa; Baruch D Kuppermann; M. Cristina Kenney

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2722. doi:

ARVO Annual Meeting Abstract June 2020

Effect of bevacizumab and aflibercept on wet AMD cybrid cells

Ahmed M Alkaliby; Jaime Toledo Corral; Paula Sakemi Fukuhara; Noor-Ul-Ain Shekoh; Cristina M Kenney; Baruch D Kuppermann

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5398. doi:

ARVO Annual Meeting Abstract July 2019

Effects of Bevacizumab on Gene Expression in ARPE-19 Cells.

Noor-Ul-Ain Shekoh; Kevin Schneider; Jacklyn Nguyen; Paula Sakemi Fukuhara; Jaime Toledo Corral; Baruch D Kuppermann; Cristina Kenney

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1943. doi:

ARVO Annual Meeting Abstract July 2019

Effects of aflibercept, estradiol and brimonidine on human Retinal Pigment Epithelial cells (ARPE-19) and Müller cells (MIO-M1) exposed to cobalt chloride (CoCl 2 ) in vitro.

Paula Sakemi Fukuhara; Daniel Hyunjae Lee; Marilyn Chwa; Noor-Ul-Ain Shekoh; Jaime Toledo Corral; Baruch D Kuppermann; Cristina Kenney

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1951. doi:

ARVO Annual Meeting Abstract July 2019

Changes in the SOD2, HIF1α and VEGFA gene expression in wet AMD cybrid cells after treatment with aflibercept or ranibizumab.

Jaime Toledo Corral; Rami San Gabriel; Paula Sakemi Fukuhara; Noor-Ul-Ain Shekoh; Tamer Hadi; Cristina Kenney; Baruch D Kuppermann

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):108. doi:

ARVO Annual Meeting Abstract July 2018

Epigenetic modifications in AMD ARPE-19 cybrids cells regulating CXCL genes

Paula Sakemi Fukuhara; Daniel Hyunjae Lee; Shari Atilano; Marilyn Chwa; Kevin Schneider; Baruch D Kuppermann; Cristina M Kenney

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4005. doi:

Advertisement